HIV/AIDS News

Low rates of children in western Kenya are being informed of their HIV status, according to study findings published in the Journal of the Pediatric Infectious Diseases Society.

June 27 marks the annual National HIV Testing Day, this year with updated screening guidelines from the US Preventive Services Task Force.

Stevens-Johnson syndrome was rare in an HIV clinic in Mbabane, Swaziland; however, of those that occurred, 84% were associated with nevirapine, according to recent study findings published in The Pediatric Infectious Disease Journal.

Efavirenz-based antiretroviral regimens were associated with less virological failure in HIV-infected children than nevirapine-based antiretroviral regimens, according to study results published in JAMA.

The US Preventive Services Task Force has recommended that all adolescents and adults aged 15 to 65 years be screened for HIV infection.

Long-term use of highly active antiretroviral therapy for HIV-infected children and adolescents appears to be cardioprotective, according to study results published in JAMA Pediatrics.

Using only nucleoside reverse transcriptase inhibitors did not offer the same duration of protection or benefits as pediatric patients treated with antiretroviral therapy, according to results from a 6-month study.

Scientists have determined how the HIV virus and a resulting strong antibody response co-evolved in one HIV-infected patient, according to a press release.

Sexual and reproductive information and services provided by HIV health care providers for adolescents and young adults with perinatally acquired HIV must be expanded to meet the needs of the growing population, new research suggests.

ATLANTA — No differences were observed in preterm birth rates or low birth weight among treatment-naive women in Uganda assigned to lopinavir-ritonavir or an efavirenz-based combination antiretroviral therapy regimen, according to late-breaker data presented here from the PROMOTE -Pregnant Women and Infant trial.